“Nightmare Bacteria” – A Wake-Up Call

In light of CDC warnings that over 200 extremely resistant superbugs were diagnosed in the US, are we doing enough?

GenMRSA_1000x465.jpg

 


The Center for Disease Control (CDC) recently warned of “nightmare bacteria” spreading across the United States. The story has been widely reported. The headlines are alarming, and rightfully so – two million Americans get antibiotic-resistant infections every year, with tens of thousands dying from those infections, said Dr. Anne Schuchat, principal deputy director of the CDC.

But what are these “nightmare bacteria”? You won’t actually see the word “nightmare” in the CDC Vital Signs report released this month, but the CDC started using the term many years ago to refer to carbapenem-resistant Enterobacteriaceae, or CRE.

 

Wherever these “nightmare bacteria” or other multi-drug-resistant organisms (MDROs) may be present, like patient rooms, operating rooms and on reusable medical equipment, infection prevention procedures can reduce the risk of transmission. Hospital cleanliness plays a significant role in reducing the transmission of these infections, and hospital cleaning teams are often not able to disinfect all surfaces in a patient room thoroughly in the allotted time. The Xenex LightStrike Germ-Zapping Robot uses pulsed xenon to quickly deliver germicidal ultraviolet (UV) light throughout patient rooms, ORs, ICUs and public areas. The Xenex LightStrike Disinfection Pod supplements room disinfection with disinfection of reusable equipment like hospital wheelchairs. A recent study in the American Journal of Infection Control (AJIC) demonstrated the Xenex robot’s efficacy against CRE, showing a 99.999 percent reduction in CRE, MRSA, VRE and Acinetobacter after the Xenex robot was used.  

 

 


 

“CRE is scary, but our robots are proven to quickly destroy it. And while the risk of someone contracting CRE in U.S. hospitals right now is low, the risk is much higher that they will get C.diff – another nightmare bacteria that’s responsible for 29,300 deaths per year (according to the CDC),” said Mark Stibich, Chief Scientific Officer of Xenex. “Hospitals using our robots have reported 50%-100% reductions in their infection rates. We have the technology to combat CRE and all the other nightmare bacteria and superbugs that people are worried about and we can do it right now.”


 

These “nightmare bacteria” should be a wake-up call for hospitals that their EVS teams on the front lines of the battle against MDROs need a fast, effective tool like our pulsed xenon UV LightStrike Robots to reduce infection rates, ensure full-coverage disinfection of high-touch surfaces and systematically disinfect rooms. With XENEX, the prescription for patient protection™, hospitals can reduce the number of people suffering from such nightmare infections.

 

 

Learn more about how XENEX LightStrike Robots and the LightStrike Disinfection Pod work, or get in touch with us to request a demo.

Credit Rachael Sparks